Skip to content

DEVOSKO: value indication

Roughly what is an SME worth on what it filed? A range from its adjusted equity and its earnings, with your own assumptions, recalculated as you go.

Value indication

DEVOSKO

BE 0840.588.241
NACE 41.001, General construction of residential buildings
latest balance sheet 30-09-2025indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€397,387 to €468,224

Midpoint €426,903 · 50% capitalised earnings, 50% adjusted equity

Adjusted equity €440,589
Capitalised earnings €354,186 to €495,860
Indication €397,387 to €468,224

Your assumptions

Capitalised earnings
%

The return a buyer expects on the money put in. Higher for more risk. The range also computes with 2 points more and less.

Adjust the equity
Blend
50%
Optional: your own multiple

Checked holds no market prices, so it suggests no multiple. If you have one from a transaction or a study, the tool applies it to the filed EBITDA less the net financial debt.

Adjusted equity

balance sheet 30-09-2025
Equity (10/15)
€440,589
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€440,589

Capitalised earnings

net result for the year (9904)
2025
€36,435
2024
€54,616
2023
€57,706
2022
€45,817
2021
€67,309
Average result
€49,586
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€354,186 / €413,217 / €495,860

What this indication leaves out

  • Market prices and comparable transactions: Checked does not hold them.
  • Anything after the latest accounts, and items off the balance sheet (guarantees, leases, disputes).
  • The real value of buildings, stock and receivables: enter your own revaluation or adjustment.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale.

For a valuation to decide on: a company auditor or a certified accountant.

Source: filed annual accounts (NBB), latest balance sheet at 30 September 2025. Prepared on 29 September 2026 via checked.be. Indication, not a valuation or advice.